By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: The Loophole That’s Made Cancer Drugs Profitable Again
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > The Loophole That’s Made Cancer Drugs Profitable Again
BusinessFinanceSpecialties

The Loophole That’s Made Cancer Drugs Profitable Again

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

The Program:

The program, known as 340B, requires most drug companies to provide hefty discounts — typically 20 to 50 percent — to hospitals and clinics that treat low-income and uninsured patients…

The Loophole:

The Program:

More Read

Screen shot 2015-06-09 at 7.18.55 PM
Having Insurance Doesn’t Always Pay: The case of the $1,700 mammogram
How Exercise Can Help Those Who Are Terminally Ill
The Evolution of Medicare Telehealth Reimbursement
New Indication for Colonoscopy: High Value Target Captured.
Here’s Everything You Need to Know About Sciatica

The program, known as 340B, requires most drug companies to provide hefty discounts — typically 20 to 50 percent — to hospitals and clinics that treat low-income and uninsured patients…

The Loophole:

The program allows hospitals to use the discounted drugs to treat not only poor patients but also those covered by Medicare or private insurance. In those cases, the hospital pockets the difference between the reduced price it pays for the drug and the amount it is reimbursed…

The Payoff:

When a private oncology practice in Memphis formed a partnership with a nearby hospital in late 2011…

ObamaCare:

The nation’s new health care law will make more hospitals eligible for the discounts by increasing the number of Medicaid patients they treat, even as the need for the discounts should arguably diminish because fewer people will be uninsured.

Monopoly:

Some oncologists say the 340B program is one reason that more than 400 oncology practices have become part of hospitals in the last several years.

Full story on the 340B program in The New York Times.

  

TAGGED:cancerpharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025
Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025
dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025

You Might also Like

how to handle tooth pain
Dental health

5 Ways to Deal With Tooth Pain at Home

April 13, 2023
Web Analytics Data, Conversion Optimization, Online Medical Marketing
BusinessFinance

What Is Your Online Marketing Data Trying to Tell You?

February 24, 2014
Healthcare Success
Business

10 Trade Secrets: How Exceptional Public Speakers Make It Look Easy

March 22, 2014
ACEP 2014 Emergency Care Report Card
Hospital AdministrationPolicy & LawPublic Health

Emergency Physicians Give Emergency Care in America a D+

January 23, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?